HealthQuill USFDA
The FDA has approved US-based DermaSensor Inc.'s handheld wireless skin cancer detection device that is powered by artificial intelligence technology.
Drugs Medical Pharma

FDA green lights DermaSensorā€™s skin cancer detection device in the US

HQ Team January 18, 2024: The FDA has approved US-based DermaSensor Inc.’s handheld wireless skin cancer detection device that is powered by artificial.

Read More
Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to treat nervous system impairment.
Drugs Health Pharma

USFDA clears AstraZeneca-Ionisā€™ drug for nervous system impairment

HQ Team December 22, 2023: Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to.

Read More
The FDA has seized ā€œthousands of unitsā€ of counterfeit weight-loss injection Ozempic which have no information about the drugā€™s identity, quality or safety.
Drugs Health Pharma

FDA starts crackdown against fake Ozempic weight-loss drugĀ 

HQ Team December 22, 2023: The FDA has seized ā€œthousands of unitsā€ of counterfeit weight-loss injection Ozempic which have no information about the.

Read More
The USFDA has approved Calliditas Therapeuticsā€™ oral drug to treat loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) and at risk of disease progression.
Drugs Health Pharma

Swedenā€™s Calliditas gets FDA nod for oral drug to treat kidney loss function

HQ Team December 21, 2023: Sweden’s Calliditas Therapeutics has got the USFDA green light for its oral drug to treat loss of kidney.

Read More
The US drug regulator has termed its Class I recall of Philips magnetic resonance systems as the ā€œmost seriousā€ type.
Drugs Health Pharma

Recall of Philips imaging devices ā€˜most seriousā€™: USFDA says

HQ Team December 21, 2023: The US drug regulator has termed its Class I recall of Philips magnetic resonance systems as the ā€œmost.

Read More
Merck announced it has got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form of kidney cancer.
Drugs Health Pharma

USFDA green lights Merckā€™s drug to treat advanced kidney cancerĀ 

HQ Team December 15, 2023: Merck announced it got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form.

Read More
The USFDA has approved two treatments for sickle cell disease, one of them the first in the US based on gene-editing technology.
Drugs Health Pharma

US drug regulator approves two treatments for sickle cell diseaseĀ 

HQ Team December 8, 2023: The USFDA has approved two treatments for sickle cell disease, one of them the first in the US.

Read More
The US Food and Drug Administration (USFDA) is assessing the potential for failures in plastic syringes manufactured in China.
Drugs Health Pharma

FDAĀ probes failure of syringes made in China for possible breakages

HQ Team December 1, 2023: The US Food and Drug Administration (USFDA) is assessing the potential for failures in plastic syringes manufactured in.

Read More
The USFDA is probing cancer therapies of Gilead Sciences, Johnson & Johnson and Novartis following reports of malignancies in patients who received treatment.
Drugs Health Pharma

FDA probing T cell cancer therapies of Gilead Sciences, Novartis, J & J

HQ Team November 29, 2023: The USFDA is probing cancer therapies of Gilead Sciences, Johnson & Johnson and Novartis following reports of malignancies.

Read More
The USFDA has officially pulled out of its membership of the Global Harmonization Working Party (GHWP), an organization currently chaired by China for the standardization of medical devices, due to a divergence of views.
Drugs Medical Pharma

FDA pulls out of 33-member medical devices body as differences emerge

HQ Team November 28, 2023: The USFDA has officially pulled out of its membership of the Global Harmonization Working Party (GHWP), an organization.

Read More